This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marchong, M. N. Articles by Gallie, B. L. Search for Related Content PubMed PubMed Citation Articles by Marchong, M. N. Articles by Gallie, B. L.

---

Cancer Genes and Genomics

Minimal 16q Genomic Loss Implicates Cadherin-11 in Retinoblastoma¹

¹ Divisions of Cancer Informatics and Cellular and Molecular Biology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; Departments of ² Medical Biophysics, ³ Molecular and Medical Genetics, and ⁴ Ophthalmology, University of Toronto, Toronto, Ontario, Canada; ⁵ Retinoblastoma Solutions, Toronto, Ontario, Canada; and ⁶ Department of Ophthalmology, West China Hospital, Faculty of Medicine, Sichuan University, Chengdu, People's Republic of China

Requests for reprints: Brenda L. Gallie, Division of Cancer Informatics, Room 8-415, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-2324; Fax: 416-946-4619. E-mail: gallie{at}attglobal.net

Retinoblastoma is initiated by loss of both RB1 alleles. Previous studies have shown that retinoblastoma tumors also show further genomic gains and losses. We now define a 2.62 Mbp minimal region of genomic loss of chromosome 16q22, which is likely to contain tumor suppressor gene(s), in 76 retinoblastoma tumors, using loss of heterozygosity (30 of 76 tumors) and quantitative multiplex PCR (71 of 76 tumors). The sequence-tagged site WI-5835 within intron 2 of the cadherin-11 (CDH11) gene showed the highest frequency of loss (54%, 22 of 41 samples tested). A second hotspot for loss (39%, 9 of 23 samples tested) was detected within intron 2 of the cadherin-13 (CDH13) gene. Furthermore, deletion of the exons of CDH11 and/or WI-5835 was shown by quantitative multiplex PCR in 17 of 30 (57%) of previously untested tumors. Immunoblot analyses revealed that 91% (20 of 22) retinoblastoma exhibited either a complete loss or a decrease of the intact form of CDH11 and 8 of 13 showed a prevalent band suggestive of the variant form. Copy number of WI-5835 for these samples correlated with CDH11 protein expression. CDH11 staining was evident in the inner nuclear layer in early mouse retinal development and in small transgenic murine SV40 large T antigen–induced retinoblastoma tumors, but advanced tumors frequently showed loss of CDH11 expression by reverse transcription-PCR, suggestive of a role for CDH11 in tumor progression or metastasis. CDH13 protein and mRNA were consistently expressed in all human and murine retinoblastoma compared with normal adult human retina. Our analyses implicate CDH11, but not CDH13, as a potential tumor suppressor gene in retinoblastoma.

This article has been cited by other articles:

				H. Dimaras, V. Khetan, W. Halliday, M. Orlic, N. L. Prigoda, B. Piovesan, P. Marrano, T. W. Corson, R. C. Eagle Jr, J. A. Squire, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma Hum. Mol. Genet., May 15, 2008; 17(10): 1363 - 1372. [Abstract] [Full Text] [PDF]

				C. B. Lupien, C. Bolduc, S. Landreville, and C. Salesse Comparison between the Gene Expression Profile of Human Muller Cells and Two Spontaneous Muller Cell Lines Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5229 - 5242. [Abstract] [Full Text] [PDF]

				S. Gratias, H. Rieder, R. Ullmann, L. Klein-Hitpass, S. Schneider, R. Boloni, M. Kappler, and D. R. Lohmann Allelic Loss in a Minimal Region on Chromosome 16q24 Is Associated with Vitreous Seeding of Retinoblastoma Cancer Res., January 1, 2007; 67(1): 408 - 416. [Abstract] [Full Text] [PDF]